Skip to content

Investigation of the relaxing effects of functional aromatic components

Investigation of the relaxing effects of functional aromatic components - Investigation of the relaxing effects of functional aromatic components

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059992
Enrollment
20
Registered
2025-12-06
Start date
2025-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

Ingestion of the test beverage Ingestion of the control beverage

Sponsors

Integrated Health Science Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy women aged 20 to 59. 2. Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily. 3. Individuals who do not meet the exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of serious diseases of the brain, nervous system, cardiovascular system, renal failure or other severe disorders. 2. Individuals with a history of seizures (such as loss of consciousness, coma, or convulsions) due to neurological disorders. 3.Individuals who are currently under treatment or those taking prescribed medications. 4. Individuals who have difficulty performing essential evaluation items in this study due to hearing or visual impairments. 5. Individuals who have olfactory or gustatory dysfunction. 6. Individuals who are currently pregnant or breastfeeding. 7. Individuals who have Citrus allergy. 8. Individuals who consumed citrus fruits, their juices, or foods containing citric acid at least three times per week within the month prior to giving consent. 9. Individuals who consumed citrus fruits, their juices, or foods containing citric acid between 8:00 p.m. on the day before the test and the start of the test. 10. Individuals who are currently participating in another clinical trial, or who have participated in another clinical trial within one months prior to obtaining consent. 11. Individuals who cannot follow the instructions for infection prevention. 12. Individuals judged as inappropriate for participation by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Autonomic nervous function, salivary stress markers, and subjective evaluation of relaxation and mood

Secondary

MeasureTime frame
Changes in performance on the fatigue-loading task and subjective fatigue assessment

Countries

Japan

Contacts

Public ContactKyosuke Watanabe

Integrated Health Science Co., Ltd. Research Division

contact@integhs.jp080-2466-6100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026